The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2

被引:232
作者
Stevenson, Lauren F.
Sparks, Alison
Allende-Vega, Nerea
Xirodimas, Dimitris P.
Lane, David P.
Saville, Mark K. [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, CRUK Cell Transformat Res Grp, Dundee DD1 9SY, Scotland
[2] Univ Dundee, Interdisciplinary Res Ctr, Div Gene Regulat & Express, Dundee DD1 4HN, Scotland
关键词
deubiquitinating enzyme; HAUSP; Mdm2; p53; USP2a;
D O I
10.1038/sj.emboj.7601567
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mdm2 is an E3 ubiquitin ligase that promotes its own ubiquitination and also ubiquitination of the p53 tumour suppressor. In a bacterial two-hybrid screen, using Mdm2 as bait, we identified an Mdm2-interacting peptide that bears sequence similarity to the deubiquitinating enzyme USP2a. We have established that full-length USP2a associates with Mdm2 in cells where it can deubiquitinate Mdm2 while demonstrating no deubiquitinating activity towards p53. Ectopic expression of USP2a causes accumulation of Mdm2 in a dose-dependent manner and consequently promotes Mdm2-mediated p53 degradation. This differs from the behaviour of HAUSP, which deubiquitinates p53 in addition to Mdm2 and thus protects p53 from Mdm2-mediated degradation. We further demonstrate that suppression of endogenous USP2a destabilises Mdm2 and causes accumulation of p53 protein and activation of p53. Our data identify the deubiquitinating enzyme USP2a as a novel regulator of the p53 pathway that acts through its ability to selectively target Mdm2.
引用
收藏
页码:976 / 986
页数:11
相关论文
共 55 条
[21]   A dynamic role of HAUSP in the p53-Mdm2 pathway [J].
Li, MY ;
Brooks, CL ;
Kon, N ;
Gu, W .
MOLECULAR CELL, 2004, 13 (06) :879-886
[22]   Divergent N-terminal sequences target an inducible testis deubiquitinating enzyme to distinct subcellular structures [J].
Lin, HJ ;
Keriel, A ;
Morales, CR ;
Bedard, N ;
Zhao, Q ;
Hingamp, P ;
Lefrançois, S ;
Combaret, L ;
Wing, SS .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (17) :6568-6578
[23]   Divergent N-terminal sequences of a deubiquitinating enzyme modulate substrate specificity [J].
Lin, HJ ;
Yin, LM ;
Reid, J ;
Wilkinson, KD ;
Wing, SS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (23) :20357-20363
[24]   Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2 [J].
Meulmeester, E ;
Maurice, MM ;
Boutell, C ;
Teunisse, AFAS ;
Ovaa, H ;
Abraham, TE ;
Dirks, RW ;
Jochemsen, AG .
MOLECULAR CELL, 2005, 18 (05) :565-576
[25]   The p53-Mdm2 module and the ubiquitin system [J].
Michael, D ;
Oren, M .
SEMINARS IN CANCER BIOLOGY, 2003, 13 (01) :49-58
[26]   THE MDM-2 ONCOGENE PRODUCT FORMS A COMPLEX WITH THE P53 PROTEIN AND INHIBITS P53-MEDIATED TRANSACTIVATION [J].
MOMAND, J ;
ZAMBETTI, GP ;
OLSON, DC ;
GEORGE, D ;
LEVINE, AJ .
CELL, 1992, 69 (07) :1237-1245
[27]   A genomic and functional inventory of deubiquitinating enzymes [J].
Nijman, SMB ;
Luna-Vargas, MPA ;
Velds, A ;
Brummelkamp, TR ;
Dirac, AMG ;
Sixma, TK ;
Bernards, R .
CELL, 2005, 123 (05) :773-786
[28]   ONCOPROTEIN MDM2 CONCEALS THE ACTIVATION DOMAIN OF TUMOR SUPPRESSOR-P53 [J].
OLINER, JD ;
PIETENPOL, JA ;
THIAGALINGAM, S ;
GVURIS, J ;
KINZLER, KW ;
VOGELSTEIN, B .
NATURE, 1993, 362 (6423) :857-860
[29]   Regulation of p53 - Intricate loops and delicate balances [J].
Oren, M ;
Damalas, A ;
Gottlieb, T ;
Michael, D ;
Taplick, J ;
Leal, JFM ;
Maya, R ;
Moas, M ;
Seger, R ;
Taya, Y ;
Ben-Ze'ev, A .
CELL SIGNALING, TRANSCRIPTION, AND TRANSLATION AS THERAPEUTIC TARGETS, 2002, 973 :374-383
[30]  
Osman I, 1999, CLIN CANCER RES, V5, P2082